Lv31
210 积分 2026-05-12 加入
Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy
1个月前
已关闭
Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy
1个月前
已关闭
Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy
1个月前
已关闭
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Mavacamten: A Novel Agent for Hypertrophic Cardiomyopathy
1个月前
已完结
Mavacamten: a novel small molecule modulator of β-cardiac myosin for treatment of hypertrophic cardiomyopathy
1个月前
已完结
In vitroandin vivopharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin
1个月前
已完结
皖公网安备34019202002308
